Featured Research
from universities, journals, and other organizations
Protein elevated in blood predicts post-concussion symptom severity in professional athletes
Date:
November 25, 2014
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
Elevated levels in the blood
of the brain-enriched protein calpain-cleaved ±II-spectrin N-terminal
fragment, known as SNTF, shortly after sports-related concussion can
predict the severity of post-concussion symptoms in professional
athletes, new research has found.
New
Penn Medicine research has found that elevated levels in the blood of
the brain-enriched protein calpain-cleaved αII-spectrin N-terminal
fragment, known as SNTF, shortly after sports-related concussion can
predict the severity of post-concussion symptoms in professional
athletes. The complete findings were released today in the Journal of Neurotrauma.
Related Articles
This new study builds on previous research from this group showing
that elevated blood levels of SNTF on the day of a mild traumatic brain
injury treated in the emergency room predicted those patients who would
go on to suffer diffuse axonal injury and long-term cognitive
dysfunction.
"We extended this biomarker research to the domain of professional sports to test its merit as an objective and rapid way to determine players' severity of brain injury," says lead author, Robert Siman, PhD, Research Professor of Neurosurgery at Penn. "This blood test may aid neurobiologically-informed decisions on suitability for return to play following a sports-related concussion."
The study, conducted in collaboration with Henrik Zetterberg, MD, PhD and Kai Blennow, MD, PhD, of the Sahgrenska Academy at University of Gothenburg, Sweden, and their colleagues, enrolled 288 players in the top Swedish professional ice hockey league. Each of the 28 players who suffered a concussion during the first half of the 2012-2013 season received serial blood draws and was evaluated daily for symptom resolution using the latest guidelines for treatment of sports concussions. Eight of the concussed players were symptom-free within a few days of their injury, but 20 of the players had persistent post-concussion symptoms requiring they be withheld from play six days or longer. An additional 45 players were evaluated during the preseason, 17 of whom were also tested before and after a concussion-free training game.
Compared to those players who were not concussed, or whose concussion symptoms resolved rapidly, the researchers found an increase in the blood SNTF concentration from one hour up to 144 hours post-concussion in those players experiencing persisting post-concussion symptoms. SNTF is a protein that is present at undetectable levels in healthy human brains, but is produced under conditions where nerve cells are traumatized and begin to die.
Concussions that lead to lasting brain dysfunction cause SNTF to accumulate in vulnerable long axon tracts of the brain, and its blood elevation is a measure of this diffuse axonal injury.
"These results show that SNTF has promise as a blood biomarker for sports-related concussion and beyond. High blood levels of SNTF appear to identify acute brain damage that corresponds with persisting symptoms after concussion. These observations lend further support to the growing awareness that concussion is not trivial, since it can induce permanent brain damage in some individuals," agree Siman and senior author, Douglas H. Smith, MD, professor of Neurosurgery and director of the Center for Brain Injury and Repair at Penn.
"We extended this biomarker research to the domain of professional sports to test its merit as an objective and rapid way to determine players' severity of brain injury," says lead author, Robert Siman, PhD, Research Professor of Neurosurgery at Penn. "This blood test may aid neurobiologically-informed decisions on suitability for return to play following a sports-related concussion."
The study, conducted in collaboration with Henrik Zetterberg, MD, PhD and Kai Blennow, MD, PhD, of the Sahgrenska Academy at University of Gothenburg, Sweden, and their colleagues, enrolled 288 players in the top Swedish professional ice hockey league. Each of the 28 players who suffered a concussion during the first half of the 2012-2013 season received serial blood draws and was evaluated daily for symptom resolution using the latest guidelines for treatment of sports concussions. Eight of the concussed players were symptom-free within a few days of their injury, but 20 of the players had persistent post-concussion symptoms requiring they be withheld from play six days or longer. An additional 45 players were evaluated during the preseason, 17 of whom were also tested before and after a concussion-free training game.
Compared to those players who were not concussed, or whose concussion symptoms resolved rapidly, the researchers found an increase in the blood SNTF concentration from one hour up to 144 hours post-concussion in those players experiencing persisting post-concussion symptoms. SNTF is a protein that is present at undetectable levels in healthy human brains, but is produced under conditions where nerve cells are traumatized and begin to die.
Concussions that lead to lasting brain dysfunction cause SNTF to accumulate in vulnerable long axon tracts of the brain, and its blood elevation is a measure of this diffuse axonal injury.
"These results show that SNTF has promise as a blood biomarker for sports-related concussion and beyond. High blood levels of SNTF appear to identify acute brain damage that corresponds with persisting symptoms after concussion. These observations lend further support to the growing awareness that concussion is not trivial, since it can induce permanent brain damage in some individuals," agree Siman and senior author, Douglas H. Smith, MD, professor of Neurosurgery and director of the Center for Brain Injury and Repair at Penn.
Story Source:
The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.
The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.
Journal Reference:
- Robert Siman, Pashtun Shahim, Yelverton Tegner, Kaj Blennow, Henrik Zetterberg, Douglas H. Smith. Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Post-Concussion Symptoms. Journal of Neurotrauma, 2014; 141124140352009 DOI: 10.1089/neu.2014.3698
Cite This Page:
Share This
More From ScienceDaily
More Mind & Brain News
Wednesday, November 26, 2014
Featured Research
from universities, journals, and other organizations
Why Do So Many Seniors With Memory Loss and Dementia Never Get Tested?
Nov. 26, 2014 — Despite clear signs that
their memory and thinking abilities have gone downhill, more than half
of seniors with these symptoms haven’t seen a doctor about them, a new
study ... full story
- Seniors: Few Seek Doctors for Memory Loss
- 'Off Switch' for Pain Discovered
- Copper On the Brain at Rest
- Enzyme That Fixes DNA Sometimes Destroys It Too
- Dogs Hear Our Words and How We Say Them
- Elderly Brains Learn, but Maybe Too Much
- Cognitive Tests For Astronauts' Brain Function
- Researchers Pinpoint Gateway to Human Memory
- Prehistoric Conflict Changed Human Brain
- Isolation of Brain Centers: Memory Deficits
newer top stories | older top stories
Featured Videos
from AP, Reuters, AFP, and other news services
Save/Print:
Share:
Breaking News:
Strange & Offbeat Stories
Health & Medicine
- Trojan Horse Tactic Gives Parasites Edge Over Immune Systems
- How Does the Brain React to Virtual Reality? Completely Different Pattern of Activity in Brain
- Pain in a Dish: Researchers Turn Skin Cells Into Pain Sensing Neurons
- Nail Stem Cells Prove More Versatile Than Press-Ons
- Life's Extremists May Be an Untapped Source of Antibacterial Drugs
No comments:
Post a Comment